Airmeet Enhances Testing Efficiency with LambdaTest for a Seamless User Experience

The adoption of LambdaTest’s device cloud, browser compatibility testing, and responsive testing has enabled Airmeet to enhance its platform’s efficiency and deliver an unparalleled user experience.

San Francisco , Nov. 27, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading cloud-based unified testing platform helped Airmeet, a leading virtual events platform known for hosting conferences, meetings, and webinars, streamline its testing process to deliver an unparalleled user experience.

Airmeet stands out in the virtual events space, providing a platform that prioritizes the attendee experience. From virtual summits and meetups to workshops, Airmeet caters to diverse virtual events, aligning its product and pricing with an attendee-centric approach. The platform offers unique networking experiences, and robust event customization and branding options.
Facing limitations with physical devices and seeking cost-effective solutions, Airmeet aimed to broaden its coverage across different manufacturers and models. The platform sought a testing platform that not only saved costs but also empowered businesses to engage with their audience, fostering growth in customer relationships and accelerating revenue.

Airmeet’s adoption of LambdaTest facilitated meticulous testing, ensuring a seamless user experience across various resolutions, browsers, operating systems, and devices. Utilizing LambdaTest’s device cloud, Airmeet conducted browser compatibility tests, guaranteeing smooth content access across different browsers. The platform also tested on multiple operating systems, including Windows, macOS, and Linux, ensuring its functionality across diverse environments. Responsive testing on various resolutions and devices, coupled with LambdaTest’s user-friendly interface, allowed Airmeet to optimize its virtual events platform efficiently.

Srikant Karanam, QA Manager, Airmeet, highlighted the extensive capabilities of LambdaTest by stating, “LambdaTest serves as a robust testing solution, offering comprehensive support across various operating systems, versions, browsers, and devices. The platform’s versatility in accommodating diverse testing environments is a key asset. LambdaTest has proven instrumental in optimizing our testing processes, ensuring compatibility, and enhancing overall efficiency in our software development lifecycle.”

By harnessing LambdaTest’s device cloud, browser compatibility testing, operating system testing, responsive testing, and user-friendly UI, Airmeet successfully ensures the seamless operation of its platform. Users can now enjoy a superior virtual event experience, irrespective of the device, browser, or operating system they choose.

Asad Khan, CEO and Co-Founder at LambdaTest said, “We are pleased to see how Airmeet has seamlessly incorporated LambdaTest into their testing framework. Our cloud-based testing platform is designed to offer a comprehensive solution, empowering organizations like Airmeet to conduct meticulous testing across diverse devices, browsers, and operating systems.”

To read more about the case study, please visit:

About LambdaTest
LambdaTest is an intelligent and omnichannel enterprise execution environment that helps businesses drastically reduce time to market through Just in Time Test Orchestration (JITTO),  ensuring quality releases and accelerated digital transformation. Over 10,000+ enterprise customers and 2+ million users across 130+ countries rely on LambdaTest for their testing needs.

● Browser & App Testing Cloud allows users to run both manual and automated tests of web and mobile apps across 3000+ different browsers, real devices, and operating system environments.

● HyperExecute helps customers run and orchestrate test grids in the cloud for any framework and programming language at blazing-fast speeds to cut down on quality test time, helping developers build software faster.

For more information, please visit,

LambdaTest press office:

GlobeNewswire Distribution ID 8985172

CRN® Names Sasha Gorbatenko of Acronis as a Channel Women on the Rise

Sasha Gorbatenko of Acronis

Sasha Gorbatenko of Acronis as a Channel Women on the Rise

BURLINGTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, is thrilled to announce that CRN®, a brand of The Channel Company, has chosen Alexandra ‘Sasha’ Gorbatenko, Channel Marketing Program Manager at Acronis, for its 2023 Channel Women on the Rise list. This annual list, formerly known as CRN Rising Female Stars, honors up-and-coming, dedicated, driven women who are leaving their mark and making a difference for solution providers throughout the IT channel. Sasha Gorbatenko stands at the forefront of channel marketing innovation while simultaneously driving positive change and empowerment within the tech industry.

As Channel Marketing Program Manager at Acronis, Sasha Gorbatenko, has over a decade of experience as a project manager in IT and digital marketing. In this role, she has demonstrated her prowess by successfully launching projects and efficiently overseeing distributed teams across the globe. Beyond her corporate responsibilities, Sasha has emerged as a trailblazer in the realm of diversity and inclusion (D&I). She spearheads international diversity programs and Women In Technology initiatives across various communities. Sasha is an advocate for gender equality in the IT sector and speaks on panels at industrial conferences and TEDx events. She is also a Platinum Tier facilitator for the Google “IAmRemarkable” program, where she conducts workshops to combat impostor syndrome, encourages participants to openly discuss their achievements, and provides individual career counseling.

“Being recognized on a list of strong women in the channel is an honor,” said Sasha Gorbatenko. “I’ve always seen the importance of fostering inclusivity and championing diversity in technology, and have had the opportunity to lead and collaborate with diverse teams over the years. This recognition only motivates me to continue advocating for positive change. I will use this to my advantage to further push the boundaries of what’s possible in our industry and inspire the next generation of leaders to embrace diversity as a strength rather than a challenge.’”

The fourth annual list of Channel Women on the Rise showcases an impressive lineup of nominees, meticulously chosen by the CRN editorial team. This selection process heavily relied on recommendations from esteemed channel chiefs and other channel management executives within the industry. These exceptional women are dedicated to supporting their channel partners in achieving success. They exhibit remarkable skills in various areas such as marketing, channel program management, and partner engagement, among others. Through their expertise, they effectively enhance their respective channel partner programs and initiatives.

“The CRN 2023 Channel Women on the Rise list showcases the women who are on the verge of becoming the future leaders and luminaries in the channel industry. These remarkable individuals consistently exhibit a strong commitment to innovation and excellence within the IT channel. Their collective efforts are instrumental in shaping a more promising future for the IT industry,” said Jennifer Follett, vice president of U.S. Content and Executive Editor of CRN at The Channel Company. “I would like to extend my congratulations to all the honorees on behalf of The Channel Company and CRN. The efforts of these emerging leaders in driving change within the IT channel will undoubtedly shape its future for years to come.”

The 2023 list of Channel will be featured online November 27th at and in the December issue of CRN Magazine released December 4th.

About Acronis
Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions powered by AI. With advanced anti-malware powered by cutting-edge machine intelligence and blockchain based data authentication technologies, Acronis protects any environment – from cloud to hybrid to on premises – at a low and predictable cost.

Acronis is a Swiss company, founded in Singapore. Celebrating two decades of innovation, Acronis has more than 2,000 employees in 45 locations. Acronis Cyber Protect solution is available in 26 languages in over 150 countries and is used by 20,000 service providers to protect over 750,000 businesses.

About The Channel Company
The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace.

Follow The Channel Company: TwitterLinkedIn, and Facebook.

© 2023 The Channel Company, LLC. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.

The Channel Company Contact:
Natalie Lewis
The Channel Company

Acronis Media Contact:
Karl Bateson

A photo accompanying this announcement is available at

GlobeNewswire Distribution ID 8985275

Philips launches HealthSuite Imaging, a cloud-based next generation of Vue PACS, with new AI-enabled clinical and operational workflows at #RSNA23

November 27, 2023

Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its enterprise imaging portfolio and AI-enabled solutions at #RSNA23. Philips HealthSuite Imaging is a next generation cloud-based PACS enabling radiologists and clinicians to adopt new capabilities faster, help improve operational efficiency and enhance patient care. HealthSuite Imaging on Amazon Web Services (AWS) offers new capabilities such as high-speed remote access for diagnostic reading, integrated reporting and AI-enabled workflow orchestration, all delivered securely via the cloud to ease IT management burden.

“The pace of customer migration to Philips HealthSuite Imaging highlights the value of cloud-enabled PACS in meeting the demands of modern day radiology departments”, said Shez Partovi, Chief Business Leader Enterprise Informatics at Philips. “HealthSuite Imaging brings AI-enabled workflow orchestration with fast remote access and integrated reporting to radiologists, anytime, anywhere.”

Philips has already migrated over 80 sites in the U.S. and in Latin America to its HealthSuite Imaging PACS running on AWS. These customers can now scale their AI-based workflow orchestration capabilities and read studies anytime from anywhere. Other healthcare systems are now planning their migration to Philips HealthSuite Imaging to take advantage of the new AI-enabled clinical and operational workflows.

One such example of a customer that has started its transition to HealthSuite Imaging is Tufts Medicine. “Tufts Medicine continues to lead the charge in delivering industry transformation through its digital health initiatives,” said Dr. Shafiq Rab, Chief Digital and Information Officer at Tufts Medicine. “In keeping with that work, we will build an enterprise-wide integrated diagnostics platform – starting with cloud-enabled radiology PACS, while ensuring the highest standards of clinical quality and data security, as part of a strategic partnership with Philips.”

Through HealthSuite Imaging, Philips continues to extend its clinical innovation focused on enhancing the radiologist experience. HealthSuite Imaging diagnostic workspace streamlines study interpretation and reporting into a single seamless application, enhanced through AI, while also enabling sophisticated image processing and simplified clinical workflows. Moreover, the cloud-based nature of HealthSuite Imaging delivers faster access to medical studies from both the hospital or remote locations. Health systems can also reduce on-premises hardware and IT management costs by moving to a secure, cloud-hosted storage platform.

Additionally, Philips will continue to work with AWS to innovate on behalf of radiologists and advance AI in healthcare by applying foundation models. Using Amazon Bedrock, Philips is exploring clinical workflow applications across its portfolio in order to automate administrative tasks and enable more accurate diagnoses.

For further information, please contact:

Anna Hogrebe
Philips Global Press Office
Tel.: +1 416 270 6757

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 70,700 employees with sales and services in more than 100 countries. News about Philips can be found at


GlobeNewswire Distribution ID 1000901189

Safety Shot, Inc Hires Securities Litigation Attorney Mark R. Basile, Esq. and The Basile Law Firm P.C. – Dilution Funding and Short and Distort Experts

JUPITER, FLORIDA., Nov. 27, 2023 (GLOBE NEWSWIRE) — Safety Shot, Inc.(NASDAQ: SHOT) (“SHOT” or the “Company”), first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity today announced that it has retained attorney Mark R. Basile and his short and distort securities litigation firm, The Basile Law Firm P.C., to investigate recent activities surrounding the company’s stock performance and to take whatever legal action necessary to prevent potential market participants utilizing unlawful means from further hurting retail investors including the recently published research paper by Capybara Research.

Mr. Basile, a former law professor, has battled dilution funding and market manipulation for the last 8 years. In 2021, his firm secured a landmark decision against a toxic dilution funder (Adar Bays) that has set the standard to save hundreds of public companies’ tens of millions of dollars. Since that decision, his firm has vacated several federal trial court judgments and consequently many of the dilution funders have not filed suits against public companies in the last 18 months.

His firm is also pursuing several RICO actions at present against known dilution funders for the collection of unlawful debt and because of his actions, the Southern District of New York recently denied a toxic lender’s motion to dismiss RICO claims. The firm has also published articles and advice for companies that believe they may be victims of dilution, counterfeit shares and market manipulation by brokers, investment relation firms and short-sellers, a summary of which can be found at:

Brian S. John, CEO of Safety Shot, Inc., said We are pleased to welcome Mr. Basile to our legal team. We are committed to legally pursue all short and distort campaigns against the company as well as all media outlets that irresponsibly reported the false, misleading and defaming Capybara Report. Mr. Basile understands how short and distort campaigns negatively affect retail shareholders and will be leading this and other litigation we plan to protect the company and its shareholders.”

About Safety Shot, Inc.
Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Safety Shot will be available for retail purchase in the first week of December 2023 at and The Company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. Safety Shot plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

Forward Looking Statements
This communication contains forward-looking statements regarding Safety Shot, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Safety Shot’s control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Safety Shot and, including those described from time to time under the caption “Risk Factors” and elsewhere in Safety Shot’s Securities and Exchange Commission (SEC) filings and reports, including Safety Shot’s Annual Report on Form 10-K for the year ended December 31, 2023 and future filings and reports by Safety Shot. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies’ forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Safety Shot on its website or otherwise. Safety Shot undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.

Media Contact:
Phone: 904-477-2306

Investor Contact:
Phone: 561-244-7100

GlobeNewswire Distribution ID 8985131

European Investment Bank to finance Iveco Group N.V. for up to 500 million euros for the decarbonisation of the transport sector



  • The financing signed represents the first tranche of 450 million euros of the 500 million total approved by the European Investment Bank (EIB) Board of Directors for the operation with Iveco Group.
  • The EIB financing is aimed at the development of cutting-edge technologies for the electrification, efficiency and safety of the transport sector.
  • The investments will be made by Iveco Group by the end of 2025, mainly in Italy,
    but also in Germany, France, Spain, the Czech Republic and Switzerland.
  • This is the first financial operation between the EIB and Iveco Group.

Turin, Italy, 27th November 2023. Contributing to the electrification, efficiency and safety of the transport sector through investments in Research, Development and Innovation: these are the main objectives of the financing granted by the European Investment Bank (EIB) to Iveco Group (EXM: IVG), a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain and related Financial Services arenas.

In detail, the loan of 450 million euros signed in Turin represents the first tranche of the 500 million total approved by the Board of Directors of the EIB. The loan, with an 8-year amortisation profile, will be drawn in full shortly. The resources made available by EIB will enable Iveco Group to develop innovative technologies and architectures in the field of electric propulsion. The Iveco Group will also increase efficiency, safety, driving comfort and productivity by further developing solutions for autonomous driving, digitalisation and vehicle connectivity. The EIB investments will not only contribute to improving electric and fuel cell vehicles, but also to reducing production costs and operating costs of the products and services, facilitating wider penetration in the market of these new technologies for the benefit of all users.

The investments will be made by the end of 2025, mainly in Italy ̶ specifically in the Iveco Group Turin and Foggia plants   ̶ but also in Germany, France, Spain, Czech Republic and Switzerland.



Gilles Badot, EIB Director for Operations in Italy, said: “Investing in projects that facilitate the development of sustainable mobility is essential to accelerate the decarbonisation of the transport sector, which is responsible for more than a quarter of the CO2 emissions in Europe. This operation with Iveco Group not only demonstrates the strong commitment of the EIB to the climate transition, but also contributes to promoting innovation and job creation in Italy and Europe.”

Marco Liccardo, Chief Technology & Digital Officer, Iveco Group, commented: “This significant financing from the EIB demonstrates trust in Iveco Group’s ability to advance sustainable mobility and our ongoing efforts to reduce the carbon footprint of the transport sector. It will enable us to accelerate the development and deployment of innovative technologies and solutions that are key to our strategic vision and the future of transport.”

About European Investment Bank 
European Investment Bank (EIB)The European Investment Bank (EIB) is the long-term financial institution of the European Union and is owned by its Member States. It provides long-term financing for valid investments in order to contribute to the EU’s strategic objectives. The Bank finances projects in four priority sectors: infrastructure, innovation, climate and environment, small and medium-sized enterprises (SMEs). Between 2019 and 2022 the EIB Group provided financing for projects in Italy for 45 billion euros.

Media Contacts:
Lorenzo Squintani,, mobile: +39 366 57 90 312
Website: – Press Office +352 4379 21000 –

Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; IDV, for highly specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; MAGIRUS, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs more than 35,000 people around the world and has 20 industrial sites and 29 R&D centres. Further information is available on the Company’s website

Media Contacts:
Francesco Polsinelli, Tel: +39 335 1776091
Fabio Lepore, Tel: +39 335 7469007

Investor Relations:
Federico Donati, Tel: +39 011 0073539


GlobeNewswire Distribution ID 1000901331

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists

– Honorary Accreditation of the Nursing Residency Program announced

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists _02

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists _02

RIYADH, Saudi Arabia, Nov. 27, 2023 (GLOBE NEWSWIRE) — The 10th International Nursing Conference commenced this morning in Jeddah, themed ‘Nurses: As Catalysts, Navigators & Innovators in Healthcare’. Organized by the King Faisal Specialist Hospital and Research Centre (KFSH&RC), the conference aims to create a unified platform for healthcare professionals to share insights and experiences. It also focuses on transforming healthcare delivery, advancing the nursing profession, and strengthening the hospital’s stature as a global leader in nursing practices.

Marking its first edition post the COVID-19 pandemic era, this year’s conference, spanning three days, features a lineup of 14 keynote sessions, 40 concurrent sessions, 10 in-depth workshops, and 55 simultaneous presentations. The expected attendance is around 650 individuals.

In a significant announcement at today’s conference, the Nursing Residency Program at Jeddah’s King Faisal Specialist Hospital and Research Center received the American Nurses Credentialing Center (ANCC) accreditation, achieving an honor status. This accreditation distinguishes the hospital as the first and only healthcare institution outside the United States to be recognized with this level of excellence by the ANCC.

The goal of the accredited Nursing Residency Program is to provide recent nursing graduates with essential knowledge and hands-on experience. This initiative is designed to ensure that they are well-prepared to deliver top-tier patient care, upholding the highest standards of healthcare excellence.

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists

KFSH&RC has been inducted into the esteemed ‘Sigma Theta Tau’ International Honor Society of Nursing. This membership, a first for any non-academic healthcare institution outside the United States, underscores the hospital’s role as a frontrunner in nursing practices, not just in the Middle East but on the global stage.

With this membership, KFSH&RC staff gain access to an extensive collection of scientific resources and world-class nursing practices from leading healthcare institutions globally. Such access is pivotal for elevating the standard of nursing care, advancing healthcare outcomes, and enhancing the overall patient experience.

Moreover, the membership allows the hospital to share its expertise and practices accumulated over more than four decades in the fields of nursing and healthcare with over 600 healthcare institutions and a network of over 100,000 members worldwide. These members are part of an association committed to advancing nursing knowledge, education, learning, and service by fostering communities of practice, education, and research.

Celebrating its 20th year, the conference is set to explore pivotal themes in the nursing sector. Top on the agenda is the integral role of nursing in achieving the ambitious objectives of Saudi Vision 2030. The event will also delve into the future of healthcare, particularly how technology and innovation are reshaping the landscape. Discussions will extend to the sustainability of healthcare services, alongside strategic insights into nurse recruitment and retention. Additionally, the conference will spotlight the latest advancements in nursing research and the critical role of evidence-based practices in modern healthcare.

The King Faisal Specialist Hospital and Research Centre stands out globally for its specialized healthcare and advanced nursing services. Notably, it has been awarded the prestigious Magnet accreditation for the third time in a row, a testament to its excellence in nursing. This accreditation, from the American Nurses Credentialing Center (ANCC), represents the global gold standard in nursing. It is an honor reserved for elite hospitals that demonstrate exceptional nursing services, high-quality patient care, innovative practices, and remarkable medical outcomes. This recognition is highly selective, with only about 8% of hospitals worldwide achieving this status.

Contact information:

Photos accompanying this announcement are available at

GlobeNewswire Distribution ID 8985260